San Diego, CA, United States of America

Morteza M Vaghefi


Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 1997-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Morteza M Vaghefi: Innovator in Oligonucleotide Modification

Introduction

Morteza M Vaghefi is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of oligonucleotide modification. With a total of five patents to his name, Vaghefi has made notable advancements in the development of crosslinking reagents and synthetic oligomers.

Latest Patents

Among his latest patents, Vaghefi has developed "Pre-activated carbonyl linkers for the modification of oligonucleotides." This invention provides a variety of compositions that comprise an activated carboxylic ester moiety on one end of an alkyl tether and a nucleic acid binding moiety on the other end. These compositions are designed for use as crosslinking reagents in conjugation reactions of nucleotides with solid support matrices, organic molecules, reporter groups, or other biomolecules. Another significant patent is for "Synthetic oligomers having chirally pure phosphonate internucleosidyl." This invention includes oligomers that have chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages, which hybridize to RNA target sequences and methods for their preparation.

Career Highlights

Vaghefi has worked with notable companies such as Genta Incorporated and Trilink Biotechnologies, Inc. His work in these organizations has contributed to the advancement of biotechnological applications and innovations in the field.

Collaborations

Throughout his career, Vaghefi has collaborated with esteemed colleagues, including Richard I Hogrefe and Lyle J Arnold, Jr. These collaborations have further enhanced his research and development efforts in oligonucleotide technologies.

Conclusion

Morteza M Vaghefi's innovative work in oligonucleotide modification has led to significant advancements in biotechnology. His patents reflect a commitment to enhancing the capabilities of nucleic acid research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…